Navigation Links
Watson Pharmaceuticals Reports Second Quarter 2008 Results
Date:8/6/2008

Watson Pharmaceuticals, Inc.

Condensed Consolidated Statements of Operations

(Unaudited; in thousands, except per share amounts)

Three Months Ended Six Months Ended

June 30, June 30,

2008 2007 2008 2007

Net revenues $622,636 $603,005 $1,249,585 $1,274,610

Cost of sales (excludes

amortization, presented below) 359,898 360,438 740,000 785,158

Gross profit 262,738 242,567 509,585 489,452

Operating expenses:

Research and development 39,216 35,503 77,231 73,311

Selling, general and

administrative 104,295 97,158 210,928 200,376

Amortization 20,190 44,159 40,369 88,092

Total operating expenses 163,701 176,820 328,528 361,779

Operating income 99,037 65,747 181,057 127,673

Non-operating (expense)

income, net:

Loss on early extinguishment

of debt - (1,681) (1,095) (4,410)

Interest income 1,685 1,803 3,994 4,732

Interest expense (6,931) (11,475) (13,727) (25,351)

Other income 2,080 3,034 7,433 6,437

Total non-operating expense,

net (3,166) (8,319) (3,395) (18,592)

Income before income taxes 95,871 57,428 177,662 109,081

Provision for income taxes 35,568 21,019 66,730 41,060

Net income $60,303 $36,409 $110,932 $68,021

Diluted earnings per share $0.53 $0.33 $0.98 $0.62

Diluted weighted a
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Watson to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Watson Receives FDA Approval for Generic Accuneb(R)
3. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
4. Watson to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
5. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
6. Barr Subsidiary Sues Watson for SEASONIQUE(R) Patent Infringement
7. Watson Files FDA Application for Generic LYBREL(R)
8. FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceuticals TRELSTAR(R) DEPOT and TRELSTAR(R) LA
9. Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals
10. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
11. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015   GenoSpace , ... the interpretation and analysis of genomic and other ... has joined the company as Vice President ... http://photos.prnewswire.com/prnh/20150730/250931 "GenoSpace partners ... integrate, interpret, analyze and explore complex sets of ...
(Date:7/30/2015)... Kan. , July 30, 2015   ... a pet therapeutics company focused on the licensing, ... companion animals, today announced that its strategic partner ... a dose confirmation study of AT-016, an adipose-derived ... for the treatment of osteoarthritis pain in dogs. ...
(Date:7/30/2015)... , July 30, 2015  Discovery Laboratories, Inc. ... has received the second $1.0M tranche under a ... (SBIR) grant valued at up to $3.0 million ... KL4 surfactant as a potential medical countermeasure to ... Labs was awarded an initial $1.0 million under ...
(Date:7/29/2015)... BANGALORE , July 30, 2015 ... Cell Market - Growth, Trends & Forecasts (2015-2020), , published ... worth US$ 30.25 billion by the end of 2020, with ... globally accounting for more than 40% of the global market ... grow at a CAGR of 13.7% during the period of ...
Breaking Biology Technology:GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 3
... Aug. 22 ZymoGenetics, Inc. (Nasdaq:,ZGEN) announced that ... to,provide an update on the regulatory review of ... be accessed on August 22 at 5:00,p.m. Eastern ... in to the call approximately 10 minutes prior ...
... Navy has awarded,Reed Group a contract to provide ... licenses for MDA for Windows. Based on The ... by Presley Reed, MD, MDA Internet and MDA ... and civilian employees of the,U.S. Navy. The ...
... in cosmetics and ... toiletries market -, LITTLE FALLS, N.J., Aug. ... of the importance of,better oral care appears to have paid off as ... a newly published study by global,management consulting and market research firm Kline ...
Cached Biology Technology:ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin 2Reed Group to Provide MDA Internet Disability Duration Guidelines to U.S. Navy 2Kline Study: Better Brushing Habits Boost European Oral Care Sales 2Kline Study: Better Brushing Habits Boost European Oral Care Sales 3
(Date:7/13/2015)... JOSE, Calif. , July 13, 2015 /PRNewswire/ ... leading developer of human interface solutions, today announced ... generation touch and display driver integration (TDDI) product ... is the first to combine Synaptics , ... with proven display driver technology developed in the ...
(Date:7/9/2015)... 2015  Unchained Labs just can,t get enough ... Avid Nano. Avid Nano designs, develops and manufactures ... Also today, Unchained Labs UNcaged the ... use protein sizing system. The pUNk is a ... size, size distribution, aggregation population and molecular weight. ...
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. (NASDAQ: ... diagnostics, today announced the launch of a study ... Precision Cancer Monitoring℠ (PCM) technology for predicting response ... or a combination of the novel immunotherapy agents ... a PD-1 inhibitor. The 50-patient study will be ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... Swiss researchers studying the projected effects of climate change ... may represent a ,safer, place to live during changing ... of Biogeography , finds that the habitat diversity of ... important for conservation. The research, led by ...
... - Researchers have created a new type of heart pump ... infants undergoing a series of surgeries to correct a deadly ... pump" for children born with univentricular circulation, a congenital heart ... defects in the first year of a child,s life, said ...
... Colo. (Nov. 9, 2010) As dog bites become an increasingly ... are most at risk for bites, that the culprits are usually ... with the second attack often more brutal than the first. ... Durairaj, MD, of the University of Colorado School of Medicine, who ...
Cached Biology News:Mountain ranges may act as "safe haven" for species facing climate change 2New heart pump to provide temporary assist for infants, adults 2New heart pump to provide temporary assist for infants, adults 3Study shows young, unsupervised children most at risk for dog bites 2